Author:
Porubcin Stefan,Rovnakova Alena,Zahornacky Ondrej,Jarcuska Pavol
Reference20 articles.
1. Serious neurological adverse events after ivermectin-do they occur beyond the indication of onchocerciasis?;Chandler;Am J Trop Med Hyg,2018
2. FDA Ivermectin prescribing information available: 〈https://www.accessdata.fda.gov/drugsatfda_docs/ label/2008/050742s022lbl.pdf〉.
3. The FDA-approved drug ivermectin inhibits the replication of SARS-CoV-2 in vitro;Caly;Antivir Res,2020
4. Ivermectin and COVID-19: keeping rigor in times of urgency;Chaccour;Am J Trop Med Hyg,2020
5. 〈https://www.fda.gov/animal-veterinary/product-safety-information/fda-letter-stakeholders-do-not-use-ivermectin-intended-animals-treatment-covid-19-humans〉.
Cited by
4 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献